Home Details
| Official Symbol of Gene | CCL5 |
| Species | Homo sapiens |
| Entrez Gene ID | 6352 |
| Official Full Name | C-C motif chemokine ligand 5 |
| Also known as | SISd; eoCP; SCYA5; RANTES; TCP228; D17S136E; SIS-delta |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000271503 MIM:187011; AllianceGenome:HGNC:10632 |
| Map Location | 17q12 |
| Detected Sample | brain |
| Sample Detail | N/A |
| Detected Method | ELISA |
| Disease | MS |
| Disease subtype | N/A |
| Population | N/A |
| Sample Size | N/A |
| Pubmed ID | 11389171 |
| Year | 2001 |
| Title | Glatiramer acetate inhibition of tumor necrosis factor-a-induced RANTES expression and release from U-251 MG human astrocytic cells |
| Expression | up-regulation |
| Risk type | Disease risk |
| Result | glatiramer acetate may exert its therapeutic effect in MS partially through inhibiting NF-kB activation and chemokine production |
| Mechanism/Pathway | our electrophoretic mobility shift assays of nuclear extracts from TNF-a-treated cells reveal an increase in DNA-binding activity specic for the nuclear factor-kappa B (NF-kB) binding site, in the 50 -ˉanking promoter region of the human RANTES gene, and that this increase in NF-kB binding activity is prevented by pretreatment with glatiramer acetate or the NF-kB inhibitors. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.